Kodiak Sciences Inc (KOD) Covered Calls

You can sell covered calls on Kodiak Sciences Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for KOD (prices last updated Tue 1:50 PM ET):

Kodiak Sciences Inc (KOD) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
9.87 +0.62 9.00 10.00 252K - 0.5
Covered Calls For Kodiak Sciences Inc (KOD)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Jan 17 10 0.30 9.70 3.1% 45.3%
Feb 21 10 0.95 9.05 10.5% 63.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase 1b clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is headquartered in Palo Alto, California.